A new genetically-engineered virus has been developed to kill cancer tumors and prevent the growth of new ones, according to a study. It was tested in 30 terminally-ill liver cancer patients and proved to significantly prolong their lives. ­The study, which was recently published in the journal Nature Medicine, describes a four-week trial of the vaccine Pexa-Vec or JX-594 marking a step forward towards...